The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of ...

For decades, cancer patients have been told that shrinking tumors meant accepting brutal side effects as the price of ...

This finding could change how we think about blood pressure and diabetes treatment. Many people take medications called ACE inhibitors to treat high blood pressure. These drugs work by blocking a ...

Nuts are a good source of plant-based protein and many other nutrients. Peanuts, almonds, and pistachios are among the ...

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Study shows treating vascular anomalies with mitogen‑activated protein kinase inhibitors results in high rates of cutaneous ...

Insilico Medicine Inc. has identified serine/threonine-protein salt-inducible kinases (SIK) inhibitors reported to be useful for the treatment of rheumatoid arthritis, nonalcoholic or metabolic ...

Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...